| 摘要 |
<p>The invention relates to a non-invasive diagnostic method of endometrial receptivity which includes collecting and comparing lipid biomarker patterns to reference lipidomic markers, particularly prostaglandins PGE2 and/or PGF2±. The method is especially applicable for determining status fertility of a mammalian female, preferably, a human female.</p> |
